Alemtuzumab Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Alemtuzumab Side Effects
Did You Have Alemtuzumab Side Effect? |
Alemtuzumab Side Effects Poll Results |
|
Vote Below:
|
|
Alemtuzumab Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Alemtuzumab:
What is Your Question? Ask Community:
Daily Health Videos
Alemtuzumab Side Effects reported on Patientsville.com
None reported at this time.Alemtuzumab Side Effects reported to FDA
Showing 1-50 of 86 Next >
Alemtuzumab Side Effects Report #5113430-XPharmacist from UNITED STATES reported Alemtuzumab side effect on Sept 21, 2006. Male patient was diagnosed with kidney transplant rejection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: chills, dyspnoea, infusion related reaction. Alemtuzumab dosage: 30 MG OVER 3 HOURS ONCE IV DRIP. During the same period patient was treated with PREDNISONE, TACROLIMUS, MYCOPHENOLIC ACID, BICARBONATE, SEVELAMER, NEPHROCAP, DARBOPOEITIN, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Alemtuzumab Side Effects Report #5474809-X
Alemtuzumab side effect was reported by a Physician from UNITED STATES on Sept 27, 2007. Female patient, weighting 97.00 lb, was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: blood triglycerides increased, chondrocalcinosis pyrophosphate, diffuse alveolar damage, encephalitis
, febrile neutropenia, histiocytosis haematophagic, hypotension, intra-abdominal haemorrhage. Alemtuzumab dosage: 30MG EVERY 3 WEEKS IV DRIP. During the same period patient was treated with ETOPOSIDE, ONCOVIN, HYDROXYLDAUNORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, NEUPOGEN, PENTAMIDINE ISETHIONATE, ACYCLOVIR. Patient died on 05/10/2007.Alemtuzumab Side Effects Report #5537517-2
Health Professional from UNITED STATES reported Alemtuzumab side effect on Nov 21, 2007. Male patient, 55 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cough, dyspnoea, encephalopathy, haemolytic anaemia, headache
. Alemtuzumab dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.Alemtuzumab Side Effects Report #5545993-4
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 26, 2007. Male patient, 25 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression, lymphoproliferative disorder and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: alveolitis fibrosing, anaemia, ascites, cryptogenic organising pneumonia, febrile neutropenia, gastrointestinal haemorrhage, hepatic cirrhosis, melaena. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, CYCLOSPORINE, RITUXIMAB. Patient died.
Alemtuzumab Side Effects Report #5558177-0
Health Professional from UNITED STATES reported Alemtuzumab side effect on Nov 21, 2007. Male patient, 55 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cough, dyspnoea, encephalopathy, haemolytic anaemia, headache
. Alemtuzumab dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.Alemtuzumab Side Effects Report #5584090-9
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 26, 2007. Male patient, 25 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression, lymphoproliferative disorder and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: alveolitis fibrosing, anaemia, ascites, cryptogenic organising pneumonia, febrile neutropenia, gastrointestinal haemorrhage, hepatic cirrhosis, melaena. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE, MELPHALAN, CYCLOSPORINE, RITUXIMAB. Patient died.
Alemtuzumab Side Effects Report #5597999-7
Physician from GERMANY reported Alemtuzumab side effect on Jan 15, 2008. Male patient, 63 years of age, weighting 149.9 lb, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, leukopenia, neutropenia, pain
, proteinuria. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TAMSULOSIN, TRIMIPRAMINMALEAT, TIOTROPIUMBROMID, FORMOTEROLHEMIFUMARAT, CIPROFLOXACIN, PREDNISOLONE. Patient was hospitalized. Patient died on 12/24/2007.Alemtuzumab Side Effects Report #5627714-X
Alemtuzumab side effect was reported by a Health Professional from MEXICO on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: multi-organ failure, sepsis
. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARA, CYCLOSPORINE, CORTICOSTEROIDS, TRIMETHOPRIM, FLUCONAZOLE OR ITRACONAZOLE, ACYCLOVIR. Patient was hospitalized. Patient died.Alemtuzumab Side Effects Report #5627853-3
Health Professional from MEXICO reported Alemtuzumab side effect on Feb 05, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, stem cell transplant, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARA, CYCLOSPORINE, CORTICOSTEROIDS, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5629376-4
Alemtuzumab side effect was reported by a Health Professional from MEXICO on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, SULFAMETHOXAZOLE, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5629377-6
Health Professional from MEXICO reported Alemtuzumab side effect on Feb 05, 2008. Male patient, 15 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: chronic graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5629378-8
Alemtuzumab side effect was reported by a Health Professional from MEXICO on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5630491-X
Health Professional from MEXICO reported Alemtuzumab side effect on Feb 05, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, stem cell transplant, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, no therapeutic response. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, CORTICOSTEROIDS, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5631858-6
Alemtuzumab side effect was reported by a Health Professional from MEXICO on Feb 05, 2008. Male patient, 15 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: chronic graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5631876-8
Health Professional from MEXICO reported Alemtuzumab side effect on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, SULFAMETHOXAZOLE, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5631877-X
Alemtuzumab side effect was reported by a Health Professional from MEXICO on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: graft versus host disease. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5632248-2
Health Professional from MEXICO reported Alemtuzumab side effect on Feb 05, 2008. Male patient, 57 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia. Alemtuzumab dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5645801-7
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 46 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: local swelling, lymphadenopathy, mycobacterium avium complex infection, neutropenia. Alemtuzumab dosage: unknown. During the same period patient was treated with FAMCICLOVIR, SULFAMETHOXAZOLEF. Patient recovered.
Alemtuzumab Side Effects Report #5660732-4
Health Professional from BELGIUM reported Alemtuzumab side effect on Feb 27, 2008. Male patient, 60 years of age, was diagnosed with intestinal t-cell lymphoma recurrent and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, thrombocytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with METHOTREXATE, ASPARAGINASE. Patient recovered.Alemtuzumab Side Effects Report #5669134-8
Alemtuzumab side effect was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #5670250-5
Physician from UNITED STATES reported Alemtuzumab side effect on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #5674865-X
Alemtuzumab side effect was reported by a Pharmacist from UNITED STATES on Mar 19, 2008. Male patient, weighting 156.5 lb, was diagnosed with t-cell lymphoma recurrent and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: cholecystitis infective, hepatic infection fungal, mucormycosis. Alemtuzumab dosage: 30MG MWF SQ. During the same period patient was treated with VORINOSTAT. Patient recovered.
Alemtuzumab Side Effects Report #5693648-8
Physician from GERMANY reported Alemtuzumab side effect on Mar 28, 2008. Female patient, 74 years of age, was diagnosed with b-cell small lymphocytic lymphoma, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: anorexia, aphasia
, central nervous system lymphoma, dizziness , encephalitis , nausea , weight decreased. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, TAVEGIL, PREDNISOLONE, ACETAMINOPHEN, KEVATRIL, DEXAMETHASONE, UROMITEXAN. Patient was hospitalized. Patient died on 03/12/2008.Alemtuzumab Side Effects Report #5694796-9
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia, enterococcal infection, klebsiella infection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: bacterial infection
, bronchopulmonary aspergillosis, febrile neutropenia, pancytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with QUINUPRISTIN, MEROPENEM. Patient was hospitalized. Patient died.Alemtuzumab Side Effects Report #5695685-6
Health Professional from UNITED STATES reported Alemtuzumab side effect on Mar 20, 2008. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia, enterococcal infection, klebsiella infection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: bacterial infection
, bronchopulmonary aspergillosis, febrile neutropenia, pancytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with QUINUPRISTIN, MEROPENEM. Patient was hospitalized. Patient died.Alemtuzumab Side Effects Report #5732705-4
Alemtuzumab side effect was reported by a Physician from GERMANY on Apr 25, 2008. Female patient, 70 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia recurrent, antiviral prophylaxis, antibiotic prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, hypertension, pyrexia. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, VALTREX, COTRIM, PARACETAMOL, TAVEGIL. Patient recovered.
Alemtuzumab Side Effects Report #5749064-3
Consumer or non-health professional from UNITED STATES reported Alemtuzumab side effect on May 07, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia, prophylaxis, infection prophylaxis, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acinetobacter infection, anaemia, angina pectoris, aspergillosis, bacterial infection
, cardiac failure congestive, chills, corynebacterium infection, cytokine release syndrome. Alemtuzumab dosage: TOTAL DAILY DOSE: 3 MG. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VALACYCLOVIR. Patient died.Alemtuzumab Side Effects Report #5762253-7
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 07, 2008. Female patient was diagnosed with immunosuppression, antiviral prophylaxis, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: meningitis cryptococcal. Alemtuzumab dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, TACROLIMUS, VALGANCICLOVIR, TRIMETHOPRIM. Patient recovered.
Alemtuzumab Side Effects Report #5771579-2
Health Professional from GERMANY reported Alemtuzumab side effect on June 04, 2008. Female patient, 64 years of age, was diagnosed with bone marrow conditioning regimen, multiple myeloma
, haematopoietic stem cell mobilisation, immunosuppression and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: cholecystitis infective, haemolytic anaemia, pneumonia , pseudomonal sepsis, respiratory failure. Alemtuzumab dosage: unknown. During the same period patient was treated with IDARUBICIN, DEXAMETHASONE, CYCLOPHOSPHAMIDE, MELPHALAN, TACROLIMUS, MYCOPHENOLATE MOFETIL, NEUPOGEN. Patient was hospitalized. Patient recovered.Alemtuzumab Side Effects Report #5773337-1
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Male patient, 62 years of age, was diagnosed with acute graft versus host disease, immunosuppression, infection prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute graft versus host disease, fungal infection
, fungal sepsis, multi-organ failure, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with BASLIXIMAB, TACROLIMUS, SIROLIMUS, PREDNISOLONE, BOLUSED STEROIDS, CYCLOPHOSPHAMIDE, ANTIBIOTICS. Patient died.Alemtuzumab Side Effects Report #5780001-1
Health Professional from UNITED STATES reported Alemtuzumab side effect on June 16, 2008. Male patient, 62 years of age, was diagnosed with acute graft versus host disease, immunosuppression, infection prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute graft versus host disease, fungal infection
, fungal sepsis, multi-organ failure, renal failure, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with BASLIXIMAB, TACROLIMUS, SIROLIMUS, PREDNISOLONE, BOLUSED STEROIDS, CYCLOPHOSPHAMIDE, ANTIBIOTICS. Patient died.Alemtuzumab Side Effects Report #5782664-3
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, urinary tract infection
, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.Alemtuzumab Side Effects Report #5787439-7
Health Professional from UNITED STATES reported Alemtuzumab side effect on June 09, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, urinary tract infection
, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.Alemtuzumab Side Effects Report #5787655-4
Alemtuzumab side effect was reported by a Consumer or non-health professional from COLOMBIA on June 14, 2008. Female patient was diagnosed with renal transplant, immunosuppression, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: pyelonephritis, urosepsis. Alemtuzumab dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with METHYLPREDNISOLONE, CYCLOSPORINE, TACROLIMUS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE, ACETAMINOPHEN. Patient died.
Alemtuzumab Side Effects Report #5795840-0
Health Professional from UNITED STATES reported Alemtuzumab side effect on June 16, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, surgical procedure repeated, transplant, transplant rejection, urinary tract infection
, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.Alemtuzumab Side Effects Report #5805486-3
Alemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on June 20, 2008. Male patient, 41 years of age, was diagnosed with infection prophylaxis, antiviral prophylaxis, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, epstein-barr virus infection, erosive duodenitis, febrile neutropenia, histiocytosis haematophagic, lymphoproliferative disorder, t-cell lymphoma. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, COTRIM, VALACYCLOVIR, FLUCONAZOLE. Patient died on 07/01/2007.Alemtuzumab Side Effects Report #5806938-2
Consumer or non-health professional from NETHERLANDS reported Alemtuzumab side effect on June 20, 2008. Female patient, 32 years of age, was diagnosed with t-cell lymphoma, infection prophylaxis, antiviral prophylaxis, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: brain neoplasm, diffuse large b-cell lymphoma, epilepsy
, epstein-barr virus infection, lymphopenia, lymphoproliferative disorder, t-cell lymphoma recurrent. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, COTRIM, VALACYCLOVIR, FLUCONAZOLE. Patient recovered.Alemtuzumab Side Effects Report #5808334-0
Alemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on June 20, 2008. Female patient, 32 years of age, was diagnosed with t-cell lymphoma, infection prophylaxis, antiviral prophylaxis, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: brain neoplasm, diffuse large b-cell lymphoma, epilepsy
, epstein-barr virus infection, lymphopenia, lymphoproliferative disorder, t-cell lymphoma recurrent. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, COTRIM, VALACYCLOVIR, FLUCONAZOLE. Patient recovered.Alemtuzumab Side Effects Report #5808335-2
Consumer or non-health professional from KOREA, REPUBLIC OF reported Alemtuzumab side effect on Mar 07, 2008. Female patient was diagnosed with bone marrow failure, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hyperbilirubinaemia, infection
, pyrexia, rash . Alemtuzumab dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOSPORINE, CIPROFLOXACIN, ACYCLOVIR, BACTRIM. Patient died.Alemtuzumab Side Effects Report #5809549-8
Alemtuzumab side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Mar 07, 2008. Female patient was diagnosed with bone marrow failure, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hyperbilirubinaemia, infection
, pyrexia, rash . Alemtuzumab dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOSPORINE, CIPROFLOXACIN, ACYCLOVIR, BACTRIM. Patient died.Alemtuzumab Side Effects Report #5811437-8
Health Professional from UNITED STATES reported Alemtuzumab side effect on July 02, 2008. Male patient, 26 years of age, was diagnosed with immunosuppression, alport's syndrome and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, dyspnoea, haemoptysis, large intestine perforation, pulmonary alveolar haemorrhage, renal failure acute, renal tubular necrosis, thrombocytopenia. Alemtuzumab dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with LISINOPRIL, CALCIUM ACETATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Alemtuzumab Side Effects Report #5814388-8
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on July 02, 2008. Male patient, 26 years of age, was diagnosed with immunosuppression, alport's syndrome and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, dyspnoea, haemoptysis, large intestine perforation, pulmonary alveolar haemorrhage, renal failure acute, renal tubular necrosis, thrombocytopenia. Alemtuzumab dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with LISINOPRIL, CALCIUM ACETATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Alemtuzumab Side Effects Report #5820080-6
Consumer or non-health professional from UNITED STATES reported Alemtuzumab side effect on Mar 18, 2008. Female patient, child 3 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, venoocclusive disease. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, METHYLPREDNISOLONE, CYCLOSPORINE, FLUCONAZOLE, VORICONIZOLE, NEUPOGEN. Patient recovered.
Alemtuzumab Side Effects Report #5836372-0
Alemtuzumab side effect was reported by a Pharmacist from UNITED STATES on Aug 06, 2008. Female patient, 61 years of age, weighting 270.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: blood bilirubin increased, disease progression, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Alemtuzumab dosage: 30MG QMWF IV. Patient was hospitalized. Patient died on 07/08/2008.
Alemtuzumab Side Effects Report #5863917-7
Health Professional from UNITED KINGDOM reported Alemtuzumab side effect on Aug 14, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #5863920-7
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis
and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.Alemtuzumab Side Effects Report #5866798-0
Health Professional from UNITED KINGDOM reported Alemtuzumab side effect on Aug 14, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis
and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.Alemtuzumab Side Effects Report #5866799-2
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: dialysis
, glomerulonephritis rapidly progressive, nephritis autoimmune, renal failure acute, renal transplant. Alemtuzumab dosage: unknown. Patient recovered.Alemtuzumab Side Effects Report #5868360-2
Health Professional from UNITED STATES reported Alemtuzumab side effect on Mar 18, 2008. Female patient, 50 years of age, was diagnosed with renal transplant and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, candidiasis, graft infection, kidney infection, renal failure acute, respiratory failure, urinary tract infection fungal. Alemtuzumab dosage: unknown. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Alemtuzumab Side Effects Report #5870151-3
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis
and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.Showing 1-50 of 86 Next >